KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer
Detecting the Kirsten Rat Sarcoma Virus (KRAS) gene mutation is significant for colorectal cancer (CRC) patients. The KRAS gene encodes a protein involved in the epidermal growth factor receptor (EGFR) signaling pathway, and mutations in this gene can negatively impact the use of monoclonal antibodi...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
IOP Publishing
2024
|
| _version_ | 1826313528545378304 |
|---|---|
| author | Singh, VK Makhlouf, Y Sarker, MMK Craig, S Baena, J Greene, C Mason, L James, JA Salto-Tellez, M O’Reilly, P Maxwell, P |
| author_facet | Singh, VK Makhlouf, Y Sarker, MMK Craig, S Baena, J Greene, C Mason, L James, JA Salto-Tellez, M O’Reilly, P Maxwell, P |
| author_sort | Singh, VK |
| collection | OXFORD |
| description | Detecting the Kirsten Rat Sarcoma Virus (KRAS) gene mutation is significant for colorectal cancer (CRC) patients. The KRAS gene encodes a protein involved in the epidermal growth factor receptor (EGFR) signaling pathway, and mutations in this gene can negatively impact the use of monoclonal antibodies in anti-EGFR therapy and affect treatment decisions. Currently, commonly used methods like next-generation sequencing (NGS) identify KRAS mutations but are expensive, time-consuming, and may not be suitable for every cancer patient sample. To address these challenges, we have developed KRASFormer, a novel framework that predicts KRAS gene mutations from Haematoxylin and Eosin (H & E) stained WSIs that are widely available for most CRC patients. KRASFormer consists of two stages: the first stage filters out non-tumor regions and selects only tumour cells using a quality screening mechanism, and the second stage predicts the KRAS gene either wildtype’ or mutant’ using a Vision Transformer-based XCiT method. The XCiT employs cross-covariance attention to capture clinically meaningful long-range representations of textural patterns in tumour tissue and KRAS mutant cells. We evaluated the performance of the first stage using an independent CRC-5000 dataset, and the second stage included both The Cancer Genome Atlas colon and rectal cancer (TCGA-CRC-DX) and in-house cohorts. The results of our experiments showed that the XCiT outperformed existing state-of-the-art methods, achieving AUCs for ROC curves of 0.691 and 0.653 on TCGA-CRC-DX and in-house datasets, respectively. Our findings emphasize three key consequences: the potential of using H & E-stained tissue slide images for predicting KRAS gene mutations as a cost-effective and time-efficient means for guiding treatment choice with CRC patients; the increase in performance metrics of a Transformer-based model; and the value of the collaboration between pathologists and data scientists in deriving a morphologically meaningful model. |
| first_indexed | 2024-09-25T04:15:43Z |
| format | Journal article |
| id | oxford-uuid:910ed29a-38ec-4589-ae2c-293a23aebe45 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:15:43Z |
| publishDate | 2024 |
| publisher | IOP Publishing |
| record_format | dspace |
| spelling | oxford-uuid:910ed29a-38ec-4589-ae2c-293a23aebe452024-07-17T20:07:15ZKRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:910ed29a-38ec-4589-ae2c-293a23aebe45EnglishJisc Publications RouterIOP Publishing2024Singh, VKMakhlouf, YSarker, MMKCraig, SBaena, JGreene, CMason, LJames, JASalto-Tellez, MO’Reilly, PMaxwell, PDetecting the Kirsten Rat Sarcoma Virus (KRAS) gene mutation is significant for colorectal cancer (CRC) patients. The KRAS gene encodes a protein involved in the epidermal growth factor receptor (EGFR) signaling pathway, and mutations in this gene can negatively impact the use of monoclonal antibodies in anti-EGFR therapy and affect treatment decisions. Currently, commonly used methods like next-generation sequencing (NGS) identify KRAS mutations but are expensive, time-consuming, and may not be suitable for every cancer patient sample. To address these challenges, we have developed KRASFormer, a novel framework that predicts KRAS gene mutations from Haematoxylin and Eosin (H & E) stained WSIs that are widely available for most CRC patients. KRASFormer consists of two stages: the first stage filters out non-tumor regions and selects only tumour cells using a quality screening mechanism, and the second stage predicts the KRAS gene either wildtype’ or mutant’ using a Vision Transformer-based XCiT method. The XCiT employs cross-covariance attention to capture clinically meaningful long-range representations of textural patterns in tumour tissue and KRAS mutant cells. We evaluated the performance of the first stage using an independent CRC-5000 dataset, and the second stage included both The Cancer Genome Atlas colon and rectal cancer (TCGA-CRC-DX) and in-house cohorts. The results of our experiments showed that the XCiT outperformed existing state-of-the-art methods, achieving AUCs for ROC curves of 0.691 and 0.653 on TCGA-CRC-DX and in-house datasets, respectively. Our findings emphasize three key consequences: the potential of using H & E-stained tissue slide images for predicting KRAS gene mutations as a cost-effective and time-efficient means for guiding treatment choice with CRC patients; the increase in performance metrics of a Transformer-based model; and the value of the collaboration between pathologists and data scientists in deriving a morphologically meaningful model. |
| spellingShingle | Singh, VK Makhlouf, Y Sarker, MMK Craig, S Baena, J Greene, C Mason, L James, JA Salto-Tellez, M O’Reilly, P Maxwell, P KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title | KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title_full | KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title_fullStr | KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title_full_unstemmed | KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title_short | KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer |
| title_sort | krasformer a fully vision transformer based framework for predicting kras gene mutations in histopathological images of colorectal cancer |
| work_keys_str_mv | AT singhvk krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT makhloufy krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT sarkermmk krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT craigs krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT baenaj krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT greenec krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT masonl krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT jamesja krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT saltotellezm krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT oreillyp krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer AT maxwellp krasformerafullyvisiontransformerbasedframeworkforpredictingkrasgenemutationsinhistopathologicalimagesofcolorectalcancer |